confirmed receipts have been $4.5m (Q1), $8.2m (Q2) & now $9m (Q3); estimating Q4 at $9.5m gives us a healthy forecasted EV to Revenue
($80m/$31.2m) of 2.5, & based on H1's $4.4m EBITDA, a conservative EV/EBITDA [$80m/4.4 + 4.4(18.5/12.7)] of 7.4; therefore i agree with the Board, "the Board continues to perceive iCandy as being undervalued:
for comparison:
- Forums
- ASX - By Stock
- ICI
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Featured News
Add ICI (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $26.88M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.1¢ | $10.77K | 506.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 494954 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 48526 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 494954 | 0.021 |
4 | 1085050 | 0.020 |
3 | 255000 | 0.019 |
2 | 543000 | 0.018 |
3 | 546969 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 48526 | 2 |
0.023 | 100000 | 1 |
0.025 | 100000 | 1 |
0.026 | 115000 | 2 |
0.027 | 67000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ICI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online